Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directions
Curr Opin Immunol. 2025 Aug 26;96:102649. doi: 10.1016/j.coi.2025.102649. Online ahead of print. ABSTRACT Acute graft-versus-host disease (aGVHD) is a significant complication of allogeneic hematopoietic cell transplantation (allo-HCT), characterized by immune-mediated tissue damage from donor immune cells. Standard treatment of aGVHD involves systemic corticosteroids, but many patients do not respond adequately, with 30%-50% of patients being … Read more